Free Research Report Download:
The Cancer Market Outlook To 2014
Free Pharmaceutical Market Research Reports
Biotechnology
Corporate & Fiscal
Drug Delivery
Health Products
Hospital Markets
Indication Areas
Medical Devices
Prescription Medicines
R&D
Custom Research
Pharmaceutical Events & Conferences
Contact
Terms & Conditions
Privacy
Home >
The Pharmaceutical Market: Finland
Management Report
Published: January 2010
Pages: 46
Tables: For full details, please email keithw@cmsinfo.com
From: GBP 595.00 Buy Now!
Research from: Espicom
Sector: Prescription Medicines
Espicom’s in-depth pharmaceutical market reports are ideal for executives wanting to understand the key drivers in pharmaceutical markets and have access to a wealth of statistical data. Each report opens with an outlook section that provides analysis of the market, 5-year market forecasts, national data projections, market outlook and key developments such as regulation, pricing/reimbursement, intellectual property, health facilities and government policy. The report also provides extensive background information, population trends, health status, health expenditure, organisation & administration, hospital services, medical personnel, healthcare development, market access information, trade data for raw materials and finished products and essential industry contacts. Included with the report are 3 free quarterly updated outlook reports, enabling you to keep up to date with market developments for a year.
The population of Finland is estimated to be 5.4 million in 2010, and the population density is extremely low at around 17.1 inhabitants per square kilometre. Finland has been hit hard by the global economic downturn, with GDP contracting by 7.1% in 2009, according to figures from the Economist Intelligence Unit, and will recover slowly with projected real growth of 0.7% in 2010 and 1.7% in 2011. Meanwhile, healthcare expenditure has continued its steady growth in the past few years.
Finland has a history of decentralised healthcare in order to provide a high level of healthcare throughout the sparsely populated country, with each of the municipalities having extensive financial responsibilities. A reference price system was introduced in April 2009 in an effort to reduce rising healthcare costs. It is hoped that the new system will reduce the use of expensive medicinal products, thus lowering the costs for patients and reducing the pressure to raise health insurance payments.
There are very few large domestic producers in Finland. The largest, Orion Pharma, claims to hold a market share of approximately 8.8%. Pfizer Oy and Leiras Oy claim to have market shares of 4.8% and 4.5%, respectively.
Imports of pharmaceuticals to Finland increased by 53.9% between 2004 and 2008 reaching US$2.3 billion in 2008. In 2008, Finland exported US$1.0 billion of pharmaceuticals, of which 94.9% was in the form of retail medicaments. Domestic production totalled 621.5 million euros (US$913.6 million) in 2008, a rise of 9.8% over 2007.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data, and healthcare personnel.
Finland has a history of decentralised healthcare in order to provide a high level of healthcare throughout the sparsely populated country, with each of the municipalities having extensive financial responsibilities. A reference price system was introduced in April 2009 in an effort to reduce rising healthcare costs. It is hoped that the new system will reduce the use of expensive medicinal products, thus lowering the costs for patients and reducing the pressure to raise health insurance payments.
There are very few large domestic producers in Finland. The largest, Orion Pharma, claims to hold a market share of approximately 8.8%. Pfizer Oy and Leiras Oy claim to have market shares of 4.8% and 4.5%, respectively.
Imports of pharmaceuticals to Finland increased by 53.9% between 2004 and 2008 reaching US$2.3 billion in 2008. In 2008, Finland exported US$1.0 billion of pharmaceuticals, of which 94.9% was in the form of retail medicaments. Domestic production totalled 621.5 million euros (US$913.6 million) in 2008, a rise of 9.8% over 2007.
Highly detailed report content
MARKET OUTLOOK
Key national data projections
Pharmaceutical Market Analysis
Current market size
Market structure
Unique 5-year market projections
Imports
Domestic manufacturing
Exports
Research & development
Pharmaceutical regulatory analysis
Including regulation, pricing & reimbursement and intellectual property
Pharmaceutical distribution
Healthcare analysis
Including demographics, healthcare system, health expenditure, healthcare infrastructure and personnel HEALTHCARE DATA
A comprehensive tabula review of the market, including economic indicators, demographics, health expenditure, hospital and primary care data, and healthcare personnel.